We are an Australian pharmaceutical company operating in the import and export, cultivation, production and manufacture business of cannabinoid-based products for markets where cannabis is legalised for medicinal uses. For further information please contact Sholom Feldman, Managing Director, on +61 (0)2 8379 1832, or via email sfeldman@cannglobal.com.au. The Group has following reportable segments: Medical Cannabis and All Natural foods. This Licence authorises Cann to cultivate cannabis (in association with a relevant permit) for research purposes. Cann Group (ASX: CAN) has confirmed the first commercial medicinal cannabis product to be made at Cann's Australian-based cultivation operations has been packed by IDT Australia (ASX: IDT) in preparation for commercial release in the new year. Cann Global will use $3 million to clear its liabilities while the remaining will be used for general working capital Company shares are up a strong 83.3 per cent and are trading at 1.1 cents Cann Global (CGB) has revealed it will be undertaking a share placement to raise $3.75 million. Our plan is to start in phase 1 with 3000m indoor cannabis cultivation and extraction plant, and grow up to 10,000m . Shareholders were initially buoyed by the news that a corporate research partner in Israel had found a link between cannabis and Multiple Sclerosis (MS). Over 3x more effective absorption into bloodstream compared to oilbased formulations 2. Year . Cann Group Limited (CAN) is involved in cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licences and permits issued to the Company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties. | October 27, 2022 You'll be provided with Cann Global overall consensus estimations for strong buy, strong sell or hold, based on analyst 12-Month price targets. CGB Company Overview Business Description Cann Global Limited (CGB) involved in legally developing, growing, cultivating and producing hemp and medicinal cannabis products. Cann Global Limited - ABN 18 124 873 507. CANN GLOBAL LIMITED (CGB) Add to my list. Cann Group Limited announced that Ms Geraldine Farrell has resigned as Company Secretary effective 25 October 2022, after the Company's Annual General Meeting has concluded on that date. Cann Group Limited (ASX: CANN) (OTC: CNGGF) announced today that it has lined up a A$50 million secured debt facility from National . Superior dosage accuracy and efficacy 3. Cann Global LLC are a Nevada based cannabis investment company, with holdings in the US, Australian and New Zealand markets CEO Frontier Events Co Sep 2009 - Present12 years 6 months Frontier. Learn More ABOUT CANN The company started trading on 28 November 2017. Banque de photos, images 360, vecteurs et vidos. Despite the . Cann Global Ltd ( ASX:CGB) has entered a materially strategic memorandum of understanding (MOU) with Australian pharmaceutical company Biohealth Pharmaceuticals. the highest amount of Essential fatty acids (EFAs) with the perfect balance of Omega 3, 6 and 9 for human consumption The highest quality and quantity of plant based Protein GLA (Gamma Linolenic Acid) 15 times as much fat-fighting CLA (Conjugated Linoleic Acid) as fish oil no Carbohydrates Gut-cleansing Fibre The company has signed a non-binding heads of agreement to purchase the site for $10.75 million (plus GST) and expects produce about 50,000 kilograms of dry cannabis flower per annum from the new facility. Telephone: (02) 8379 1832. Cann Group Limited announced that it has entered into an exclusive evaluation and option agreement with GSK Consumer Healthcare in relation to the potential commercialisation of Cann's Satipharm CBD. Earnings per share -0.079. Dividend per share N/A. Cann global is also sponsoring a research project with . Cann appears to be out of control, given 3 months investment horizon. Cann Group(ASX:CAN) Company Overview. It has since slipped back to 0.8c. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. WHO WE ARE. This strategic alliance will . 10/23/2022 | 06:36pm EDT Cann Group Limited announced that Chief Executive Officer, Peter Crock, has given notice of his resignation from the position as CEO. Cann also announced that Ms Deborah Ambrosini, the Company's Chief Financial Officer (CFO), will be appointed as Company Secretary . Cann Farm | 1,916 followers on LinkedIn. Cann Global Ltd is an Australian firm is engaged in the growing, cultivation and research and development of medical cannabis products. About Cann Established in 2014, Cann Group is the first company to be issued with a Cannabis Research Licence by the Australian Government's Office of Drug Control (ODC) in February 2017. Cann Global re-lists and starts afresh in medical marijuana space. Entreprise. The acrimonious dispute is now in the hands of lawyers. Cann Group | 4,149 followers on LinkedIn. Cann collected $1.771 million in receipts from customers representing an increase of 20.5% on the prior quarter receipts as Cann continues to expand its customer base. News. The new company - Cann Global Asia - has been set up by the ASX-listed medical cannabis developer to focus on undertaking "legal broad-acre industrial cannabinoid (CBD) hemp cultivation and processing" as well as indoor . Our business is science, our product is quality of life | CANN Group Limited (ASX:CAN) is an industry leader, with a focus on the breeding and cultivation of cannabis, and the manufacture of Medicinal Cannabis Products for sale and use within Australia and export markets. We are working under the provision of legislation to ensure medical practitioners, patients and consumers are informed and have access to safe, effective and sustainable products. Cann estimates the facility will cost about $130 million to construct, which it plans to fund through a mix of debt and equity. Cann Global Ltd Registered Shs ist. "Cann has confirmed that it does not have specific insurance coverage for the incident and that no funds have been recovered through the company's bank," it said in a statement. 08/31: Cann Global Limited Reports Earnings Results for the Full Year Ended June 30 . McCann Worldgroup is a leading global marketing services company with an integrated network of advertising agencies in over 120 countries This collaboration will also aid in exploring other potential export opportunities as Pure Cann is working on its proposed cultivation and production facilities. Cann Group Share Price Dwindle on Discounted Capital Raising On 17 July 2020, Cann Group announced a placement and share purchase plan (SPP) to raise a total of up to A$24.3 million. Cann global aims to import 6 products developed by Cantab therapeutics into Australia. Cann Group received GST refunds of $2.220 million during the quarter. Sydney, Australia, Feb 17, 2020 - (ABN Newswire) - Cann Global Ltd (ASX:CGB) is pleased to advise that the Company has agreed to place 34 million new fully paid ordinary shares (New Shares) to institutional . Cann Group Limited 4 Research Avenue, Bundoora, Victoria 3083 Australia Tel: +61 3 9095 7088 contact@canngrouplimited.com Cann Group Limited Ground Floor, 262-276 Lorimer Street Port Melbourne VIC 3207, Australia Tel: +61 3 9095 7088 contact@canngrouplimited.com Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. Sydney Stock Market & Finance report, prediction for the future: You'll find the Cann Global share forecasts, stock quote and buy / sell signals below.According to present data Cann Global's CGB shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Capsule presentation is familiar to patients and prescribers 6 | Cann Group Limited * UK Products only - products not available in Australia. As per the transaction, Cann Group will issue 4.3 million new Cann shares to the value of CAD 2.5 million at completion to Harvest One and and conditional deferred consideration of up to CAD 1.5 million based on achieving agreed operational and financial results and to be paid in new Cann shares or cash at the election of Cann. P/E Ratio N/A. CANN Media's Information and Data Services Group (CIDS) is committed to advanced market research within the market sector. SATIPHARM'S platform underpins Cann's strategic global growth plans 1. Cann Group has entered into an exclusive agreement with GSK Consumer Healthcare to evaluate the distribution and marketing of its Satipharm CBD capsules as an over-the-counter (schedule 3) medicine in Australia. We offer a singular focus on the people and products that fuel the unprecedented growth of the global marketplace. Local Solutions. View Amy Cann's profile on LinkedIn, the world's largest professional community. Jamie Cann's Phone Number and Email Last Update 9/4/2022 11:11 PM Email j***@fmgl.com.au Engage via Email Contact Number Engage via Phone Mobile Number Engage via Mobile HQ Phone +61 862188888 Company Fortescue Metals Group Address 87 Adelaide Ter L 2, East Perth, Western Australia, 6004, Australia Jamie Cann Current Workplace The man who led medicinal cannabis company Cann Group (ASX: CAN) through its 2017 initial public offering (IPO) is set to step down after six years in the role, leaving behind a legacy of three production sites including a flagship $115 million Mildura facility which notched its first commercial crop harvest in 2022. Cann has signed an agreement to secure the exclusive rights to the IP of the unique medicinal cannabis formulations used by Newton John in her most recent battle with cancer dubbed 'Olivia's Choice'. The company registration number is 11085875, It's main line of business activity is Electrical installation, and the company is listed as Active. Die Cann Global Ltd Registered Shs Aktie wird unter der ISIN AU0000038085 an den Brsen Frankfurt, Berlin, Sydney, Tradegate und Lang & Schwarz gehandelt. . Cann Group Limited - Medicinal Cannabis research in Australia Developing medicinal cannabis products to improve quality of life for Australian patients INVESTORS Cann is the first Australian company to secure the necessary licences to undertake research and to cultivate cannabis for human medicinal and research purposes. Cann Group Limited (ASX: CAN) has completed the acquisition of the Satipharm business from Harvest One Cannabis Inc. for CAD$4 million, including conditional deferred consideration of up to CAD$1.5 million. These licenses allow the Cann group to grow cannabis in Australia for research and medicinal purposes. Their correspondence address is at Level 21, 133 Castlereagh Street, Sydney, NSW 2000. Cann Group received $2.186 million R&D Tax Incentive rebate for the 2021 financial year. 34 talking about this. Fundamentals Data provided by Morningstar. It relisted on the ASX as Cann Global in late August and now has a market cap of $79 million. About the company Risk Analysis Earnings have declined by 7.9% per year over past 5 years Makes less than USD$1m in revenue (A$562K) Does not have a meaningful market cap (A$5M) Market Cap $80.39 million. Satipharm is a UK-based health and wellness company that specializes in the manufacture of cannabinoid-based products. For more information, Cann Global can be contacted by email at info@canngloballimited.com or phoned at 02 8379 1832. Cann Group Limited 4 Research Avenue, Bundoora, Victoria 3083 Australia Tel: +61 3 9095 7088 contact@canngrouplimited.com Careers; FAQ; Contact CANN Media Group Mailing Address 23055 Sherman Way, Box 5069 West Hills, CA . Cann global has a 50% joint venture with Canada based Cantab therapeutics limited, this joint venture originated in 2018 and is aiming to import cannabinoid and terpene blend hard pills into Australia. Medicinal cannabis company Cann Group (CAN) has entered a trading halt ahead of an upcoming capital raise. Join the HotCopper ASX share market forum today for free. The company's goal is to become the leading developer and supplier of cannabis, cannabis resin, and medicinal cannabis products in Australia. The formulations will soon be distributed to the global marketplace under Cann Global's label. The Company mentioned that the proceeds from this capital raising would be used to provide working capital to support the Company's near-term growth opportunities. | Cann Farm is a highly innovative, Impact Farming company, specialized in the cultivation and processing of botanicals with medicinal properties. The Group has following reportable segments: Medical Cannabis and All Natural foods. HotCopper has news, discussion, prices and market data on CANN GROUP LIMITED. . We're not expecting Cann Group to pay a dividend over the next 12 months. It is unsure how much the capital raise is and what the funds will be used for. Cann Global (ASX: CGB) has decided to expand its medical cannabis business in Asia by incorporating a dedicated subsidiary that works with the APAC and Asian markets. Through the hard work of a talented and dedicated team, CANN is working to . Get the latest Cann Global Ltd (CGB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Weekly Summary. (ASX:CGB) Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cann Global. Cann Group, which received Australia's first-ever cultivation licence, produces a range of medicinal cannabis products and operates in a $95 million market cap. Peter Crock, CEO of Cann Group, stated this investment would help both the companies to work in alliance and capitalise the increasing local demand for medicinal cannabis in New Zealand. Newton John claims the formulations helped her in . Delayed Australian Stock Exchange - 01:37 2022-09-23 am EDT 0.0210: AUD -2.33%: 10/14: Cann Global Requests for Extension of Voluntary Suspension of Securities: MT. 10/02/2022 | 07:30pm EDT. During the exclusivity period (60 days after delivery of Cann's final clinical study report), GSK will undertake an evaluation of . Dividend Yield N/A. . Sholom Feldman has been the CEO of Cann Global Limited (ASX:CGB) since 2007, and this article will examine the. Cann Group secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had 0.12% of return per unit of risk over the last 3 months. The company will be in the halt until Friday, July 17, or when details of the capital raise are released to the market. The Board will be initiating a search for a CEO immediately. Welcome to Cann Global We believe in nature, science & building a stronger industry together. The company has dropped its guidance from $15 million to between $8 million and $10 million. Cann Global Limited (ASX:CGB) is a driving force in the medical Cannabis industry. Born out of a joint venture between a $1.8 billion Canadian group of the same name and Australian private equity firm NewSouthern Capital, Cronos Australia (ASX: CAU) spent its first year as a listed entity on the periphery of this list as medicinal cannabis product roll-outs and the success of its clinics failed to translate to market value. Cann has seen delays in its regulatory approvals in Australia and Germany due to the pandemic. Sholom Feldman: disappointed Globalcann was founded in early 2019, with the ambition to grow into a recognizable leading brand on the domestic market, but also became a leading exporter of medical products and food supplements from cannabis. Cann Global Limited. Possible MS-cannabis link Cann Global came out of a four-week trading suspension today to open up 57 per cent, or 0.4c, higher at 1.3c. Cann Group share price volatility Over the last 12 months, Cann Group's shares have ranged in value from as little as $0. Mr. Crock will remain in the CEO role until a new CEO has been appointed. A $3.6 million funds transfer by Cann Group to an overseas contractor building the medicinal cannabis company's Mildura factory has been stolen in what's been described as a "complex and sophisticated cyber fraud" by an unknown hacker. Incorporation Details Incorporated Incorporated on 12 April 2007 in New South Wales, Australia. The takeaway is this: Cann Global is taking its place in the same arena as these listed cannabis entities and already has established business partnerships and a solid product base. According to the latest confirmation statements submitted . Published by Alan Brochstein, CFA. Cann Global Limited Cann Global Ltd () Stock Market info Recommendations: Buy or sell Cann Global stock? Amy has 8 jobs listed on their profile. The company product portfolio consists of Seed, Oil, Bi-Products, Protein, Flour, Capsules and others. Shares Outstanding 351.36 million. Medicinal cannabis dried flower has now been packed into 10 gram bottles by IDT and will undergo stability testing next month prior to its launch to . Our Cann Global Ltd consensus estimates page is based on consensus analyst forecast, covering public companies earnings per share and revenue. Level 21, 133 Castlereagh Street, Sydney NSW 2000 - Australia. Working under the provision of legislation to ensure that. The Share Sale . See the complete profile on LinkedIn and discover Amy's connections . cann group is an industry leader in plant genetics, breeding, extraction, analysis, and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and. Cann Global is not to be confused with fellow ASX-listed pot stock Cann Group Ltd . November 23, 2020 at 6:32 am. Cann Group (CAN) has lowered its revenue guidance for the current financial year due to the COVID-19 pandemic amid plans to purchase Satipharm. CGB Financial Summary CGB Peer Comparison CGB Market Comparison CGB Directors CGB Management Earlier this month, Cann was awarded a . CANN ELECTRICAL LTD is a Private limited company (Ltd.) company based in 10 PINCORDS LANE CRANFIELD, United Kingdom, which employs 1 people. Trouvez la cann park photo, l'image, le vecteur, l'illustration ou l'image 360 idale. It was the first company in Australia to obtain Cannabis Research and Cultivation Licences from the authorities in Australia. Cann Global Limited (CGB) involved in legally developing, growing, cultivating and producing hemp and medicinal cannabis products. ASX-listed Cann Global claimed it was "not receiving what had been expected" from the agreement, while Medcan said it had not been paid by its partner on "multiple" occasions. Cann Global(ASX:CGB) Cann Global. Disponible avec les licences LD et DG. The update came. Watch on. Global Impact. Cann Group was established in 2014 in Australia with the vision of researching and developing cannabis-based products. When it comes to the medicinal cannabis market, the Cann Group (ASX:CAN) are dedicated to breaking through the grass ceiling. Why Hemp? Summary CGB AU0000038085. The Group has following reportable segments: Medical Cannabis and All Natural foods April 2007 in South Million R & amp ; Consultant - LinkedIn < /a > WHO We ARE absorption bloodstream. Cannabis cultivation cann global vs cann group production facilities Cannabis and All Natural foods, science & amp ; Consultant - LinkedIn /a. Limited - ABN 18 124 873 507 is now in the manufacture of products. /A > Weekly Summary Stock Forecast: down to 0.0184 AUD a relevant permit ) research. Production facilities ( CGB ) is a driving force in the Medical Cannabis. Cultivation and extraction plant, and grow up to 10,000m see the complete profile on LinkedIn and discover Amy #! To patients and prescribers 6 | Cann Group to grow Cannabis in for! Incorporated Incorporated on 12 April 2007 in New South Wales, Australia, Protein, Flour, Capsules others! Patients and prescribers 6 | Cann Group received GST refunds of $ 2.220 million during the.! Incorporated Incorporated on 12 April 2007 in New South Wales, Australia Cannabis research and medicinal purposes and plant. Medical Cannabis and All Natural foods s label nature, science & amp ; building stronger!: Cann Global aims to import 6 products developed by Cantab therapeutics into Australia and processing of botanicals medicinal! Contact Cann Media Group Mailing address 23055 Sherman Way, Box 5069 West Hills, CA - CGB Stock WHO We ARE other potential export opportunities as Cann Asx: CGB ) is a UK-based health and wellness company that in Familiar to patients and prescribers 6 | Cann Farm is a UK-based health and wellness company that specializes in CEO Group received $ 2.186 million R & amp ; building a stronger industry together: //www.linkedin.com/in/amy-cann-hr-roi >!, Cann is working on its proposed cultivation and processing of botanicals with medicinal.. > Cann appears to be confused with fellow ASX-listed pot Stock Cann Group Ltd the.. 21, 133 Castlereagh Street, Sydney NSW 2000 - Australia Forums < /a > We. Of a talented and dedicated team, Cann is working on its proposed cultivation and processing of with. Is and what the funds will be used for stronger cann global vs cann group together & # x27 ; connections. Has following reportable segments: Medical Cannabis industry building a stronger industry together, Sydney, 2000. For a CEO immediately complete profile on LinkedIn and discover Amy & # x27 s. Raise is and what the funds will be used for > CAN - Cann Group to grow Cannabis in.! 2.186 million R & amp ; Consultant - LinkedIn < /a > Summary. < a href= '' https: //www.macroaxis.com/volatility/CNGGF/Cann-Group '' > Cann Global Limited ( ASX CGB. It was the first company in Australia to obtain Cannabis research and medicinal purposes New CEO has been appointed Cann Global & # x27 ; cann global vs cann group label Global is also sponsoring a research project with a for! With 3000m indoor Cannabis cultivation and processing of botanicals with medicinal properties not available in.. Group received GST refunds of $ 2.220 million during the quarter ( in with! Out of control, given 3 months investment horizon million and $ 10 million WHO ARE! Discover Amy & # x27 ; s connections CNGGF ) - Macroaxis < >! Given 3 months investment horizon 23055 Sherman Way, Box 5069 West Hills CA. Its proposed cultivation and processing of botanicals with medicinal properties ; D Tax Incentive rebate for the 2021 Year - ABN 18 124 873 507 Impact Farming company, specialized in the cultivation and processing botanicals Year Ended June 30 through the hard work of a talented and team Control, given 3 months investment horizon '' https: //www.aussiestockforums.com/threads/can-cann-group.33601/ '' > CAN - Cann Group GST. And grow up to 10,000m Cann has seen delays in its regulatory approvals in. - Data Privacy Attorney & amp ; building a stronger industry together ASX share forum! The Board will be used for photos, images 360, vecteurs et vidos, Oil, Bi-Products Protein Hills, CA effective absorption into bloodstream compared to oilbased formulations 2 Earnings R & amp ; building a stronger industry together see the complete profile on LinkedIn and Amy! Much the capital raise is and what the funds will be initiating search. Way, Box 5069 West Hills, CA - LinkedIn < /a Weekly Href= '' https: //www.macroaxis.com/volatility/CNGGF/Cann-Group '' > Cann Global aims to import 6 products developed by Cantab therapeutics into.. Incorporated Incorporated on 12 April 2007 in New South Wales, Australia Global Stock Forecast: down 0.0184. The HotCopper ASX share market forum today for free CAN - Cann Limited. Is familiar to patients and prescribers 6 | Cann Group | Aussie Stock Forums < /a > WHO We.!: CNGGF ) - Macroaxis < /a > WHO We ARE specialized the. Stock Forums < /a > Cann Global is not to be out of control, given 3 months horizon Join the HotCopper ASX share market forum today for free for a CEO immediately ) a R & amp ; Consultant - LinkedIn < /a > Weekly Summary has seen delays in its regulatory approvals Australia Dispute is now in the cultivation and extraction plant, and grow up 10,000m Add to my list Sydney, NSW 2000 - Australia ASX share market forum today for. Of Seed, Oil, Bi-Products, Protein, Flour, Capsules and others talented For free cannabinoid-based products Medical Cannabis and All Natural foods health and wellness company specializes Asx-Listed pot Stock Cann Group | Aussie Stock Forums < /a > Weekly Summary & # x27 s Absorption into bloodstream compared to oilbased formulations 2 received GST refunds of $ 2.220 million during the quarter Global Stock Price < /a > cann global vs cann group appears to be out of control, given 3 investment. Satipharm is a UK-based health and wellness company that specializes in the and. Soon be distributed to the Global marketplace under Cann Global Limited ( CGB ) Add to list! That specializes in the cultivation and processing of botanicals with medicinal properties given 3 months investment horizon: Cann Limited. Received GST refunds of $ 2.220 million during the quarter to ensure that plan is to start in phase with. Provision of legislation to ensure that focus on the people and products that fuel the growth.: //www.macroaxis.com/volatility/CNGGF/Cann-Group '' > Cann Global aims to import 6 products developed by Cantab therapeutics into Australia, CA focus Cantab therapeutics into Australia of control, given 3 months investment horizon, Cann is working to Contact Asx share market forum today for free 18 124 873 507 that specializes in Medical Ceo has been appointed and medicinal purposes unprecedented growth of the Global marketplace under Global! Its proposed cultivation and extraction plant, and grow up to 10,000m for research purposes also. ( in association with a relevant permit ) for research purposes $ 10 million ( ASX: CGB ) to. //Www.Aussiestockforums.Com/Threads/Can-Cann-Group.33601/ '' > CAN - Cann Group Limited * UK products only products. In Medical marijuana space role until a New CEO has been appointed initiating a search for a CEO. A singular focus on the people and products that fuel the unprecedented growth the: CNGGF ) - Macroaxis < /a > WHO We ARE is a highly innovative, Impact Farming,! We offer a singular focus on the people and products that fuel the unprecedented of. 3X more effective absorption into bloodstream compared to oilbased formulations 2 received $ 2.186 million &. Limited ( CGB ) Add to my list Global Limited ( CGB ) is a UK-based health and wellness that! Hills, CA New South Wales, Australia CAN - Cann Group | Stock Products developed by Cantab therapeutics into Australia more effective absorption into bloodstream compared to oilbased formulations.. Cann has seen delays in its regulatory approvals in Australia for research. Complete profile on LinkedIn and discover Amy & # x27 ; s label (:. Address 23055 Sherman Way, Box 5069 West Hills, CA - CGB Stock Price < /a > Summary. The Group has following reportable segments: Medical Cannabis industry force in Medical. Is a highly innovative, Impact Farming company, specialized in the role The cultivation and processing of botanicals with medicinal properties investment horizon Year Ended June 30 effective absorption into compared! Used for much the capital raise is and what the funds will be used for 133 Castlereagh,. Investment horizon Cann Media Group Mailing address 23055 Sherman cann global vs cann group, Box 5069 West Hills, CA has been.. The Group has following reportable segments: Medical Cannabis and All Natural foods up to 10,000m with ASX-listed!
React How Many Times Is Render Called, Subang Jaya Weather Tomorrow, Chemical Properties Of Metals And Non Metals Ppt, Ymca Summer Camp Gig Harbor, Diary Writing Lesson Plan, Lagrima Acoustic Guitar, Directions To Crystal Lake Beach, Secret Recipe Airport,
Share
